Event Program

View the Full Program for the 6th Gene Therapy for Ophthalmic Disorders Summit

This summit is your unique forum to learn and network with the brightest minds revolutionizing the industry. View your copy of the latest agenda to view the full speaker faculty, details about each session, and registration options.

6th_Gene_Therapy_for_Ophthalmic_Disorders_Summit_Thumbnail

Having trouble downloading the brochure?
Let us know here and we’ll email it to you instead

Speaker Spotlight: Cherie Fathy

Cherie Fathy, Alnylam Pharmaceuticals

Former FDA Clinical Reviewer, Now Director of Clinical Research at Alnylam Pharmaceuticals

With experience as a former FDA Clinical Reviewer and Medical Officer - having left the Agency as recently as June 2025 - Cherie Fathy brings both fresh regulatory perspective and industry insight to one of ophthalmic gene therapy’s toughest challenges: novel endpoint development. Don’t miss the chance to hear what truly resonates with regulators - check out her session in the program!

Get Ready For:

18+

Senior specialists sharing end-to-end ophthalmic gene therapy expertise

3+

Hours of exclusive clinical data from Atsena, Tern, & Adverum Therapeutics

2+

Hours of preclinical research insights from Sparing Vision, Axovia, & Coave Therapeutics

6+

Hours of high-yield networking with industry leaders & vendors

50:50

Preclinical and clinical content split across 3 days

Register Today
Partner With Us

Contact Us Today

Reach out to us to chat about the agenda, explore group discounts, get help with registering, or for anything else you need!

Email us at info@hansonwade.com or call us on +1 617 455 4188

Contact Us
Bethany Hammond

Bethany Hammond
Delegate Audience Manager